clinically localized prostate cancer

0:20:52

AUA/ASTRO/SUO Guidelines on Clinically Localized Prostate Cancer

0:01:48

Prolaris Testing in Men With Clinically Localized Prostate Cancer

0:51:48

4.30.2020 Urology COViD Didactics - Treatment for Clinically Localized Prostate Cancer

0:20:37

Role of Lymphadenectomy in the Surgical Treatment of Clinical Localized Prostate Cancer

0:56:03

'Prostate Abscess' and 'Genomic Biomarkers for Clinically Localized Prostate Cancer”

0:14:14

Trials in Neoadjuvant Therapy for Patients with High-Risk Localized Prostate Cancer

0:07:50

NCCN Guidelines for Treatment of Localized Prostate Cancer

0:03:10

Genetic predisposition to early recurrence in clinically localized prostate cancer

0:01:10

Robert B. Den, MD, on the QOL differences between clinically localized prostate cancer patients

0:02:57

Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer

0:04:45

Prostate Cancer Treatment: Understanding Your Options

0:40:36

Role of Decipher in Managing High Risk Localized Prostate Cancer

0:12:52

Biomarkers in Localized Prostate Cancer: Sure You Can But Why Would You?

0:02:49

Doctor Explains the ProtecT Trial

0:01:51

Updates on the treatment landscape of high-risk localized prostate cancer

0:04:11

Understanding Localized Prostate Cancer

0:03:26

Treatment Options for Localized Prostate Cancer - Urology Care Foundation

0:00:59

ProtecT trial: a battle between three treatments for patients with localized prostate cancer

0:02:38

Dr. Mason Discusses the PROTECT Study in Localized Prostate Cancer

0:00:55

Cure Rates For Localized, Non-Metastatic Gleason 8 & 9 #ProstateCancer With Modern Medicine. #PCRI

0:04:58

EAU TV: Evaluating the effectiveness of treatment for clinically localised prostate cancer

0:04:06

Niraparib for DDR-Deficient Localized Prostate Cancer: Results From a Phase 2 Study

0:17:57

Neuroendocrine prostate cancer

0:11:58

Optimal treatment of clinically node-positive prostate cancer in the PSMA PET/CT era